• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZHANG Tao,WU Yuqian,LU Shushu,PEI Keling.Research progress of Shugan Jieyu Capsules in the treatment of coronary heart disease complicated with major depressive disorder[J].Journal Of Pharmaceutical Research,2025,44(5):507-511[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2129times   Download 747次 QR Code for this article
Scan with your phone!
舒肝解郁胶囊治疗冠心病合并抑郁症的研究进展
张涛1,吴钰倩2,路淑淑2,裴可灵2
Font:Larger+|Default|Smaller-
(1.山东电力中心医院,山东 济南 250001;2.山东大学附属精神卫生中心,山东 济南 250014)
摘要:
抑郁是冠心病(CHD)发生发展的独立危险因素之一,CHD合并抑郁症(MDD)可增加其治疗难度,严重影响患者的身心健康。舒肝解郁胶囊(SG)是由贯叶金丝桃和刺五加组成的纯中药制剂,具有疏肝解郁和健脾安神的功效。近年来,中药治疗CHD合并MDD已成为心血管疾病领域的研究热点。然而,SG是否能给CHD合并MDD患者带来长期获益仍存争议。本文对SG治疗CHD合并MDD的基础和临床研究进展进行综述,以期为CHD合并MDD的临床合理用药提供科学依据。
关键词:  舒肝解郁胶囊  冠心病  抑郁症  中药  合理用药
DOI:10.13506/j.cnki.jpr.2025.05.014
基金项目:山东省中医药科技项目(No.M-2022200)
Publication Date:May 25, 2025
Research progress of Shugan Jieyu Capsules in the treatment of coronary heart disease complicated with major depressive disorder
ZHANG Tao1,WU Yuqian2,LU Shushu2,PEI Keling2
(1.Shandong Electric Power Central Hospital,Jinan 250001,China;2. Shandong Mental Health Center Affiliated to Shandong University,Jinan 250014,China)
Abstract:
Depression is one of the independent risk factors for the occurrence and development of coronary heart disease (CHD). CHD combined with major depressive disorder(MDD) could not only increase the difficulty of treatment, but also seriously affect the physical and mental health of patients. Shugan Jieyu Capsule (SG) is a traditional Chinese medicine(TCM) which composed of Hypericum perforatum and Acanthopanax. SG has the effects of soothing liver and relieving depression and strengthening spleen and calming nerves. In recent years, TCM treatment of CHD combined with MDD has become a focus in the field of cardiovascular diseases. However, whether SG can provide long-term benefits for patients with CHD combined with MDD remains controversial. This article reviewed the basic and clinical research progress of SG in the treatment of CHD combined with MDD, in order to provide scientific basis for clinical therapy of CHD combined with MDD.
Key words:  Shugan Jieyu capsule  Coronary heart disease  Major depressive disorder  Traditional chinese medicine  Rational drug use
Today's Visits:509    Total Visits:2383239
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.